Adell Harriman & Carpenter’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $42.9M | Buy |
170,667
+855
| +0.5% | +$184K | 2.2% | 10 |
|
|
2026
Q1 | $36.9M | Sell |
169,812
-880
| -0.5% | -$195K | 2.25% | 9 |
|
|
2025
Q4 | $39M | Buy |
170,692
+1,596
| +0.9% | +$364K | 2.33% | 11 |
|
|
2025
Q3 | $39.2M | Buy |
169,096
+1,447
| +0.9% | +$295K | 2.38% | 9 |
|
|
2025
Q2 | $31.1M | Sell |
167,649
-3,144
| -2% | -$584K | 2.06% | 14 |
|
|
2025
Q1 | $35.8M | Sell |
170,793
-3,669
| -2% | -$713K | 2.7% | 10 |
|
|
2024
Q4 | $31M | Buy |
174,462
+2,721
| +2% | +$500K | 2.16% | 13 |
|
|
2024
Q3 | $33.9M | Buy |
171,741
+845
| +0.5% | +$158K | 2.47% | 11 |
|
|
2024
Q2 | $29.3M | Buy |
170,896
+1,389
| +0.8% | +$230K | 2.26% | 11 |
|
|
2024
Q1 | $30.9M | Buy |
169,507
+857
| +0.5% | +$148K | 2.54% | 8 |
|
|
2023
Q4 | $26.1M | Sell |
168,650
-2,435
| -1% | -$355K | 2.42% | 9 |
|
|
2023
Q3 | $25.5M | Sell |
171,085
-1,999
| -1% | -$293K | 2.65% | 6 |
|
|
2023
Q2 | $23.4M | Sell |
173,084
-5,698
| -3% | -$836K | 2.37% | 7 |
|
|
2023
Q1 | $28.5M | Sell |
178,782
-919
| -0.5% | -$141K | 3.06% | 4 |
|
|
2022
Q4 | $29M | Sell |
179,701
-133
| -0.1% | -$20.4K | 3.34% | 4 |
|
|
2022
Q3 | $24.1M | Buy |
179,834
+1,867
| +1% | +$268K | 2.94% | 5 |
|
|
2022
Q2 | $27.3M | Sell |
177,967
-1,497
| -0.8% | -$229K | 3.34% | 5 |
|
|
2022
Q1 | $29.1M | Sell |
179,464
-862
| -0.5% | -$125K | 2.83% | 6 |
|
|
2021
Q4 | $24.4M | Buy |
180,326
+1,301
| +0.7% | +$154K | 2.27% | 7 |
|
|
2021
Q3 | $19.3M | Buy |
179,025
+4,298
| +2% | +$491K | 2.01% | 9 |
|
|
2021
Q2 | $19.7M | Buy |
174,727
+7,380
| +4% | +$831K | 2.07% | 9 |
|
|
2021
Q1 | $18.1M | Buy |
167,347
+9,096
| +6% | +$973K | 2.2% | 7 |
|
|
2020
Q4 | $17M | Buy |
158,251
+17,929
| +13% | +$1.72M | 2.23% | 7 |
|
|
2020
Q3 | $12.3M | Buy |
140,322
+10,466
| +8% | +$985K | 1.83% | 12 |
|
|
2020
Q2 | $12.7M | Buy |
129,856
+34,236
| +36% | +$3.01M | 2.18% | 9 |
|
|
2020
Q1 | $7.29M | Buy |
95,620
+4,075
| +4% | +$347K | 1.54% | 19 |
|
|
2019
Q4 | $8.11M | Buy |
91,545
+6,600
| +8% | +$548K | 1.33% | 23 |
|
|
2019
Q3 | $6.43M | Buy |
84,945
+9,147
| +12% | +$627K | 1.16% | 30 |
|
|
2019
Q2 | $5.51M | Sell |
75,798
-3,260
| -4% | -$256K | 1.03% | 36 |
|
|
2019
Q1 | $6.37M | Sell |
79,058
-6,832
| -8% | -$559K | 1.24% | 27 |
|
|
2018
Q4 | $7.92M | Sell |
85,890
-613
| -0.7% | -$53.9K | 1.75% | 20 |
|
|
2018
Q3 | $8.18M | Buy |
86,503
+1,128
| +1% | +$107K | 1.53% | 22 |
|
|
2018
Q2 | $7.91M | Sell |
85,375
-3,999
| -4% | -$391K | 1.57% | 24 |
|
|
2018
Q1 | $8.46M | Sell |
89,374
-5,589
| -6% | -$614K | 1.75% | 19 |
|
|
2017
Q4 | $9.18M | Sell |
94,963
-3,953
| -4% | -$373K | 1.94% | 17 |
|
|
2017
Q3 | $8.79M | Sell |
98,916
-1,447
| -1% | -$110K | 1.92% | 18 |
|
|
2017
Q2 | $7.28M | Sell |
100,363
-1,149
| -1% | -$77.2K | 1.65% | 21 |
|
|
2017
Q1 | $6.61M | Sell |
101,512
-2,447
| -2% | -$154K | 1.52% | 21 |
|
|
2016
Q4 | $6.51M | Sell |
103,959
-3,752
| -3% | -$229K | 1.62% | 17 |
|
|
2016
Q3 | $6.79M | Buy |
107,711
+300
| +0.3% | +$19.4K | 1.72% | 17 |
|
|
2016
Q2 | $6.65M | Buy |
107,411
+5,496
| +5% | +$335K | 1.74% | 15 |
|
|
2016
Q1 | $5.82M | Buy |
101,915
+125
| +0.1% | +$6.97K | 1.57% | 22 |
|
|
2015
Q4 | $6.03M | Buy |
101,790
+24,900
| +32% | +$1.43M | 1.62% | 18 |
|
|
2015
Q3 | $4.18M | Buy |
76,890
+4,317
| +6% | +$281K | 1.23% | 33 |
|
|
2015
Q2 | $4.88M | Buy |
72,573
+9,385
| +15% | +$613K | 1.26% | 24 |
|
|
2015
Q1 | $3.7M | Sell |
63,188
-6,896
| -10% | -$417K | 0.97% | 38 |
|
|
2014
Q4 | $4.59M | Buy |
70,084
+7,720
| +12% | +$487K | 1.25% | 26 |
|
|
2014
Q3 | $3.52M | Hold |
62,364
| – | – | 0.97% | 36 |
|
|
2014
Q2 | $3.52M | Buy |
62,364
+6,325
| +11% | +$332K | 0.97% | 36 |
|
|
2014
Q1 | $2.88M | Buy |
56,039
+12,300
| +28% | +$622K | 0.85% | 44 |
|
|
2013
Q4 | $2.31M | Sell |
43,739
-300
| -0.7% | -$14.7K | 0.72% | 48 |
|
|
2013
Q3 | $1.97M | Buy |
44,039
+5,049
| +13% | +$224K | 0.55% | 49 |
|
|
2013
Q2 | $1.61M | Buy |
+38,990
| New | +$1.71M | 0.58% | 54 |
|
Other funds holding ABBV
Adell Harriman & Carpenter's ABBV Position: Q2 2026 in Review
Adell Harriman & Carpenter increased its AbbVie (ABBV) stake by 0.5% in Q2 2026, buying an estimated $184K and bringing the position to 170,667 shares worth $42.9M. The position accounts for 2.2% of the portfolio, ranked #10.
Adell Harriman & Carpenter first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Adell Harriman & Carpenter held 170,667 shares of AbbVie worth $42.9M as of Q2 2026.
- Adell Harriman & Carpenter bought 855 AbbVie shares in Q2 2026, an estimated $184K.
- AbbVie made up 2.2% of Adell Harriman & Carpenter's portfolio in Q2 2026, its #10 holding.
- Adell Harriman & Carpenter first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Adell Harriman & Carpenter's 13F filing for Q2 2026, filed 4 Aug 2026.